id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1368227,a49614ea-df16-42a4-b216-46682193ea4f,Q1,"COMPASS STRATEGIES, LLC",299172,"IMMUNETICS, INC.",2013,first_quarter,MED,Issues pertaining to blood supply safety and the promotion of blood platelet bacterial contamination detection,"Veterans Affairs, Dept of (VA)",,,0,0,2013-02-20T05:16:43.533000-05:00
1368407,35a84532-1125-4811-899c-be0253ac7930,Q1,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2013,first_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2013-04-01T09:36:52.617000-04:00
1368489,addacb28-6dbf-4ea2-9af1-1c830fc52cea,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2013,first_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,111725,0,0,2013-04-01T11:54:32.130000-04:00
1368595,48f8e4fe-4ed3-4c6c-821b-e8d90e9a1e32,Q1,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2013,first_quarter,MED,all matters dealing with pharmaceutical labeling,Food & Drug Administration (FDA),25000,,0,0,2013-04-02T09:59:35.863000-04:00
1368670,4b793e0e-37d6-497b-9150-d416dc1c230e,1A,TEXTILE RENTAL SERVICES ASSOCIATION,37937,TEXTILE RENTAL SERVICES ASSOCIATION,2013,first_quarter,MED,Support of HR 523 and S 232,"Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2013-04-02T15:48:39.010000-04:00
1368735,5b35fa5a-06c8-4c7b-81e2-3bc8403f4a0e,Q1,ASSN OF MEDICAL DEVICE REPROCESSORS,291732,ASSN OF MEDICAL DEVICE REPROCESSORS,2013,first_quarter,MED,"Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally.  Contacted VA about regulations for reprocessed single-use medical devices.","HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,,0,0,2013-04-03T12:53:26.947000-04:00
1368769,6707b9dd-8ce4-48c9-99d9-f69739211b4a,Q1,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2013,first_quarter,MED,Legislation and issues related to Alzheimer's Disease Research,"Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office",10000,,0,0,2013-04-03T14:55:44.430000-04:00
1368987,3759ec48-133f-47ce-9936-c83e8b6e1f8d,Q1,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2013,first_quarter,MED,NIH Budget including Title VII & VIII programs-Sequestration,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,145000,0,0,2013-04-05T11:11:42.163000-04:00
1369249,d15d1944-6d6b-4b94-9a3c-4cc502798711,Q1,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2013,first_quarter,MED,"FY 2012 Appropriations
Residency Caps
Minority Improvement
NIOSH Education and Research Centers for Occupational Health and SafetyPrevention Research Centers
Resident Physician Shortage
Health Care Reform
FY 2013 Appropriations
FY 2014 Appropriations","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)",,29312,0,0,2013-04-08T11:14:59.307000-04:00
1369321,dc779930-4ee5-42b4-8d12-0035f016ce41,Q1,CEPHEID,400270233,CEPHEID,2013,first_quarter,MED,"See page fiveLobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs
CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE",,70000,0,0,2013-04-08T14:05:48.973000-04:00
1369398,ac0f7a32-9443-456b-a70f-e329bac9574b,Q1,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2013,first_quarter,MED,"Labor/HHS/Education Appropriations Bill 2013: Provisions relating to diseaes research, education, and development","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-08T15:25:28.363000-04:00
1369440,bb86fed5-08f9-45a0-a649-798a51e2dedd,Q1,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2013,first_quarter,MED,Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research,"Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2013-04-08T15:56:43.660000-04:00
1369810,fb40f6b2-d2e6-497a-9bef-720687b77e69,Q1,AMERICAN GASTROENTEROLOGICAL ASSOCIATION,59650,AMERICAN GASTROENTEROLOGICAL ASSOCIATION,2013,first_quarter,MED,Lobbied in support of federal funding of biomedical research and funding for the National Institutes of Health (NIH).,"HOUSE OF REPRESENTATIVES,SENATE",,80000,0,0,2013-04-09T16:23:27.447000-04:00
1370010,a1f44752-ab57-4dc7-a2b6-c8b62c581255,1T,MCDERMOTT WILL & SCHULTE LLP,24338,UNITED ALLERGY SERVICES,2013,first_quarter,MED,Support for allergy and asthma awareness and education.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,1,2013-04-10T11:31:32.240000-04:00
1370243,e95b3507-7360-4679-87dd-836c5e2c2db4,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,COALITION FOR 21ST CENTURY MEDICINE,2013,first_quarter,MED,Issues concerning regulation of laboratory tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2013-04-10T14:39:09.987000-04:00
1370268,d28e9cb4-8b39-4593-934a-b1c9fb66b7b3,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,GENOMIC HEALTH INC,2013,first_quarter,MED,FDA regulation of laboratory-developed tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-10T14:51:20.667000-04:00
1370306,bffce533-94b5-427a-8c6f-acf8a0377eb0,1T,"THE CJR GROUP, INC.",288293,STERIS CORPORATION,2013,first_quarter,MED,Biomedical issues,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,1,2013-04-10T15:17:46.533000-04:00
1370315,3c340d31-238a-4cbd-9392-56163d5379e4,Q1,PALMETTO GROUP,18570,INTERNATIONAL AIDS VACCINE INITIATIVE,2013,first_quarter,MED,"Federal Funding of AIDS vaccine
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2014",SENATE,15000,,0,0,2013-04-10T15:38:52.273000-04:00
1370434,0d129149-56a3-40ac-a171-6caa1fd0dc30,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2013,first_quarter,MED,"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 - Support funding for medical treatments for HIV positive patients.  Support appropriate funding for the ADAP program.Continue appropriate funding for Chronic Care Special Needs clinics under Medicare.  Provisions included in Continuing Resolution, P.L. 113-6.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-10T17:38:00.270000-04:00
1370455,6e9730c0-6eb8-4ba4-8ad9-32628c877906,Q1,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2013,first_quarter,MED,Medical issues relating to hospitals,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-04-11T08:47:16.490000-04:00
1370530,b9143905-3c29-41a2-b4c2-6a4b7fdb3bfd,Q1,"THE CONAFAY GROUP, LLC",401004840,CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP,2013,first_quarter,MED,Improving the enviroment for antibiotic drug development,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2013-04-11T10:12:05.983000-04:00
1370701,b8803514-7222-4afb-ba2f-a007a9b56347,Q1,PHOENIX CHILDREN'S HOSPITAL,400381743,PHOENIX CHILDREN'S HOSPITAL,2013,first_quarter,MED,"Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions.","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2013-04-11T13:37:15.650000-04:00
1370991,73fc6599-b243-44f9-8c8a-76f00d2656f8,Q1,"THE CORMAC GROUP, LLC",66773,KESSLER FOUNDATION,2013,first_quarter,MED,"Appropriations, DOD, TBI research","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-12T12:30:41.187000-04:00
1371344,200866ab-2b22-411f-89c9-f273098166d8,Q1,MR. MICHAEL ROMANSKY,400418985,"OUTPATIENT OPHTHALMIC SURGERY SOCIETY, INC",2013,first_quarter,MED,ASC access to iv drugs,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE",45000,,0,0,2013-04-12T17:36:40.713000-04:00
1371480,c187c884-204f-4a9d-b8f6-3931bc4a4aab,Q1,BEN BARNES GROUP LP,5415,FAIR LABORATORY PRACTICES ASSOCIATION,2013,first_quarter,MED,Bring attention to prevention of unfair billing practices by laboratories for Medicare services,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-04-14T16:21:29.040000-04:00
1371560,02fbde19-90ab-4658-a3cf-671e8a8753d0,Q1,"SABISTON CONSULTANTS, LLC",323557,PENNINGTON BIOMEDICAL RESEARCH CENTER,2013,first_quarter,MED,Funding for initiatives and research on behalf of obesity issues.,SENATE,10000,,0,0,2013-04-14T21:49:24.347000-04:00
1371669,51182f00-99ee-4ef5-9ec8-a3376bec8d06,Q1,"MEHLMAN CONSULTING, INC.",284950,AMERICAN CLINICAL LABORATORY ASSOCIATION,2013,first_quarter,MED,"Health reform law implementation issues including application of medical device tax to clinical laboratory tests and laboratory fee schedule.      
In-office ancillary services exception to Stark Law.    
FDA oversight of laboratory-developed tests.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",80000,,0,0,2013-04-15T10:18:14.130000-04:00
1372295,2d984d37-e0b9-463b-8f01-97e2ef1cc17c,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,PATH,2013,first_quarter,MED,Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-15T14:35:45.317000-04:00
1372336,e0d6795c-e78a-463d-bba7-29c02373b2da,Q1,PERSONALIZED MEDICINE COALITION,40046362,PERSONALIZED MEDICINE COALITION,2013,first_quarter,MED,"Personalized medicine regulation, CMS coverage of personalized medicine diagnostics, CER and Genomics, FDA regulation of personalized medicine","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2013-04-15T14:43:58.747000-04:00
1372368,dbced34c-0654-41d4-b602-d749d590c377,Q1,GOLDBUG STRATEGIES LLC,400701094,COALITION FOR 21ST CENTURY MEDICINE,2013,first_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-15T14:54:13.083000-04:00
1372377,4be0dd50-fdf5-4a54-84b9-8c5c14c34e8c,Q1,GOLDBUG STRATEGIES LLC,400701094,GENOMIC HEALTH INC.,2013,first_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-15T14:58:17.500000-04:00
1372430,32031d9c-f496-4fa1-a4ba-29e7c9ee5dcb,Q1,GOLDBUG STRATEGIES LLC,400701094,LIFE TECHNOLOGIES/THERMO FISHER,2013,first_quarter,MED,"regulation of medical devices, in vitro diagnostics and  laboratory developed tests","Food & Drug Administration (FDA),SENATE",,,0,0,2013-04-15T15:24:41.730000-04:00
1372622,1924eeee-4c27-4d9d-bb95-674d8f38f4b6,Q1,"THE CONAFAY GROUP, LLC",401004840,"ZIOPHARM ONCOLOGY, INC.",2013,first_quarter,MED,Educated members of the House of Representatives on the importance of encouraging innovatio,SENATE,50000,,0,0,2013-04-15T17:15:18.920000-04:00
1372780,ba70c14f-fd81-4488-8cef-d70684fa48dd,Q1,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2013,first_quarter,MED,"Appropriations for USDA ARS human nutrition centers in the Consolidated and Further Continuing Appropriations Act, 2013, and for FY14","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-15T23:25:39.257000-04:00
1373235,8c732b43-5d8b-47d9-9328-4577e8a0dff7,Q1,THE OUTLAW GROUP,46095,AMERICAN TINNITUS ASSOCIATION,2013,first_quarter,MED,"Legislation to promote research by NIDCD/NIH to prevent, treat and cure tinnitus.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2013-04-16T13:01:46.907000-04:00
1373441,c13d871a-7f47-42a2-8dff-2ab9a99c2203,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2013,first_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2013-04-16T14:47:26.453000-04:00
1373460,f23dcbd8-9a87-49c9-b23f-fba879446b4f,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2013,first_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2013-04-16T14:53:33.417000-04:00
1373477,5b3485a2-bc54-48cf-9cc9-2966d22c8d60,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2013,first_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2013-04-16T15:00:39.710000-04:00
1373500,7bac7818-33e5-48ed-9aee-974b1255923c,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2013,first_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2013-04-16T15:07:50.657000-04:00
1373529,6c4143a5-3893-4102-b38c-3f527702f812,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2013,first_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2013-04-16T15:12:59.027000-04:00
1373643,7f231f6c-d67e-4ed1-8e2c-1b262740806c,Q1,"THE CORMAC GROUP, LLC",66773,MIAMI BEACH COMMUNITY HEALTH CENTER,2013,first_quarter,MED,"funding for medical equipment through appropriations process, Labor HHS, health care facilities funding, community health centers","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-16T15:58:45.383000-04:00
1373727,cb8c0f88-995a-48f1-9ea4-8e17fda5d77c,Q1,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,400382759,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,2013,first_quarter,MED,Urging members of Congress to support the Great Ape Protection and Cost Savings Act.,"HOUSE OF REPRESENTATIVES,SENATE",,23910,0,0,2013-04-16T16:40:31.737000-04:00
1373766,60d54afc-a2d1-4d0e-af61-8be8607c809f,Q1,"THE CORMAC GROUP, LLC",66773,MIAMI JEWISH HEALTH SYSTEMS,2013,first_quarter,MED,"HHS Appropriations, heath care facilities, IT funding for nursing homes, federal grants and veterans programs","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-16T17:07:48.123000-04:00
1373837,5c5a9144-13ca-4cde-ad0d-dd778aa306ea,Q1,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2970,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2013,first_quarter,MED,HR 1098 - Traumatic Brain Injury Reauthorization Act of 2013:  Support passage.,"HOUSE OF REPRESENTATIVES,SENATE",,150000,0,0,2013-04-16T17:24:09.267000-04:00
1373935,93cadae1-522a-4021-8638-aa622b4fefa1,Q1,BROYDRICK & ASSOCIATES,7268,EXACT SCIENCES,2013,first_quarter,MED,FDA/CMS approval process for cancer screening test.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-16T19:54:13.647000-04:00
1374167,5f8bcebd-2e14-4ac2-83db-087a08a60974,Q1,CHILDREN'S HOSPITAL BOSTON,9066,CHILDREN'S HOSPITAL BOSTON,2013,first_quarter,MED,"Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,50000,0,0,2013-04-17T10:32:33.127000-04:00
1374311,0386fe82-bd50-496e-95a5-3d87ca377609,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,INTERNATIONAL MYELOMA FOUNDATION,2013,first_quarter,MED,Cancer Drug Coverage Parity Act,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-17T11:09:36.220000-04:00
1374331,15968130-4470-42d0-82ee-310ee058cb94,1T,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,DIADEXUS INC,2013,first_quarter,MED,Prevention of cardiovascular disease.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2013-04-17T11:12:43.560000-04:00
1374354,b85bdb78-7b7e-48b9-b9ba-c4ae78973eb8,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ONYX PHARMACEUTICALS,2013,first_quarter,MED,"Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages.  Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2013-04-17T11:17:55.417000-04:00
1374375,541b2836-dae7-409a-8f33-d871e2d5f475,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,CRESCENDO BIOSCIENCE INC.,2013,first_quarter,MED,"Biomedical research, treatment of rheumatoid arthritis, public-private partnerships, oversight and reimbursement of laboratory testing.","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2013-04-17T11:21:06.693000-04:00
1374388,c382759b-81b1-4198-a45d-37bc95b00a1b,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION FOR MOLECULAR PATHOLOGY,2013,first_quarter,MED,"Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care;  
HR 1309: Health Information Technology Reform Act","Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE",30000,,0,0,2013-04-17T11:24:13.627000-04:00
1374411,dc4d215c-0161-41bc-901e-b85b0b063212,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2013,first_quarter,MED,"No Bill #, Labor-HHS-Education Appropriations Bill, FY 2014, Tuberous Sclerosis
No Bill #, Defense Appropriations, FY 2014 Defense health programs, Tuberous Sclerosis Complex Research Program
Department of Defense, Military Construction and Veterans Affairs, and Full-Year Continuing Appropriations Act, 2013 H933","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-17T11:32:29.843000-04:00
1374675,a77a8d1f-5345-42c9-a0a1-701e6fb59eb6,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION),2013,first_quarter,MED,"Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",46000,,0,0,2013-04-17T12:28:32.737000-04:00
1374693,b964d4cf-7ebf-4b87-9fc2-2c07dc285c95,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,SANOFI PASTEUR,2013,first_quarter,MED,"Vaccine research and development legislation, funding, appropriations and oversight.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office",46000,,0,0,2013-04-17T12:32:44.747000-04:00
1374717,4a3e7034-67d3-4cf4-b3c9-60ae65452ed7,Q1,"DALRYMPLE & ASSOCIATES, LLC",5073,DISCOVERY LABORATORIES,2013,first_quarter,MED,"Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",,,0,0,2013-04-17T12:37:55.337000-04:00
1374729,202c2ec9-f809-4026-ade7-9fc171d16dfc,Q1,"WITT O'BRIEN'S, LLC (F/K/A WITT GROUP HOLDINGS, LLC)",76491,INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS,2013,first_quarter,MED,"S.3187: Food and Drug Administration Safety and Innovation Act, Provisions affecting the edical device industry, H.R.436: Health Care Cost Reduction Act of 2012 provisions related to the medical device excise tax S.262  A bill to repeal the excise tax on medical device manufacturers.",HOUSE OF REPRESENTATIVES,10000,,0,0,2013-04-17T12:42:02.787000-04:00
1374873,f1f6a787-40af-466c-9d30-e49e671036d9,Q1,SRI INTERNATIONAL,90990,SRI INTERNATIONAL,2013,first_quarter,MED,"DoD, MilCon/VA and Full-Year Continuing Appropriations (HR 933)
FY14 House and Senate Labor/HHS/Education Appropriations","HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2013-04-17T13:12:00.590000-04:00
1374920,7f95d30a-4355-48f7-91fd-dfe7d89b9f40,1T,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION,2013,first_quarter,MED,"HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease
HR 933 Department of Defense, Military Construction and Veterans Affairs, and Full-Year Continuing Appropriations Act, 2013, defense health programs, reasearch for bone marrow failure disease","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,1,2013-04-17T13:26:16.407000-04:00
1375137,76a57a2c-7590-4ae5-9db6-e31c159b1dad,Q1,THORN RUN PARTNERS,400534596,ABBOTT LABORATORIES,2013,first_quarter,MED,"Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.",,30000,,0,0,2013-04-17T14:32:47.387000-04:00
1375143,64a11504-1d5e-4f9c-b759-23fa84968765,Q1,FIRST STRATEGIC,91091,PHOENIX CHILDREN'S HOSPITAL,2013,first_quarter,MED,"Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-17T14:34:49.790000-04:00
1375237,c21464f4-ba7a-4886-8da3-440786eb5ad5,Q1,"K&L GATES, LLP",32098,SMITS SPEIDELL CONSULTING,2013,first_quarter,MED,Yet to be introduced:  A bill to amend the Internal Revenue Code of 1986 to broaden the special rules for certain governmental plans under section 105(j) to include plans established by political subdivisions.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-17T14:55:26.107000-04:00
1375478,e7bb1798-13f6-46b7-aeae-81d2c5deac36,Q1,WEBMD HEALTH CORP.,55473,WEBMD HEALTH CORP,2013,first_quarter,MED,"Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers.  Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records",SENATE,,30000,0,0,2013-04-17T15:43:10.787000-04:00
1375484,dbef12d9-040b-488a-a661-ccae3a38035c,Q1,THORN RUN PARTNERS,400534596,CHILDRENS HOSPITAL COLORADO,2013,first_quarter,MED,Issues related to clinical research.,Centers For Medicare and Medicaid Services (CMS),20000,,0,0,2013-04-17T15:45:11.677000-04:00
1375588,e6b74149-b335-4dd0-8b7f-c33bbc31b40f,Q1,"HARRISON RIVARD DUNCAN & BUZZETT, CHTD.",72257,HCA HEALTHCARE,2013,first_quarter,MED,Health and Medical Issues,,,,0,0,2013-04-17T16:04:51.003000-04:00
1376025,67274390-6811-45fa-b98d-fcae82de8495,Q1,THORN RUN PARTNERS,400534596,NOVARTIS CORPORATION,2013,first_quarter,MED,Issues related to biologics.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-17T22:52:26.517000-04:00
1376190,6f1f18de-64d6-4851-82f0-4da018a62f47,Q1,LIFE TECHNOLOGIES CORPORATION,400391833,LIFE TECHNOLOGIES CORPORATION,2013,first_quarter,MED,"Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
No bill numbers to date:  BETTER Care Act/Modernizing Laboratory Test Standards for Patients Act of 2011/Medical Testing Availability Act;  Provisions regarding lab developed tests.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2013-04-18T09:08:50.193000-04:00
1376323,cd0c8040-0196-44c6-b769-47ca4a9b23ce,Q1,PRINCETON UNIVERSITY,308695,PRINCETON UNIVERSITY,2013,first_quarter,MED,"S. 810; H.R. 1513: ""Great Ape Protection and Cost Savings Act of 2011,"" Section 3: ""Definition of Great Ape;"" Section 4: ""Prohibitions,"" meaning of invasive research","Education, Dept of,Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE,White House Office",,110000,0,0,2013-04-18T10:15:46.637000-04:00
1376631,48fb306b-c33a-4eba-9337-f4b2cf5c2529,Q1,BEN BARNES GROUP LP,5415,"ROYALTY PHARMA - / RP MANAGEMENT, LLC",2013,first_quarter,MED,"Tax reform, Master Limited Partnership","HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2013-04-18T11:20:46.337000-04:00
1376753,9fd006c8-bffc-425d-9db3-16be648dece4,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2013,first_quarter,MED,"Appropriations and Authorization legislation for FY 2013 and FY 2014 in health care
HR933 Department of Defense, Military Construction and Veterans Affairs, and Full-Year Continuing Appropriations Act, 2013","Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2013-04-18T11:36:30.377000-04:00
1376846,cf931d83-f141-40da-add6-6e27e5a602e2,Q1,PRIME POLICY GROUP,400532589,"VERAX BIOMEDICAL, INC.",2013,first_quarter,MED,Blood Safety,HOUSE OF REPRESENTATIVES,30000,,0,0,2013-04-18T12:12:11.210000-04:00
1376884,5b35c265-043f-4d32-bd1b-70c682951925,Q1,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2013,first_quarter,MED,NCATS,"Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,2610000,0,0,2013-04-18T12:17:27.833000-04:00
1376993,aa23e58d-1800-4556-893a-d845b23172e5,Q1,BEN BARNES GROUP LP,5415,TEXAS A&M SYSTEM,2013,first_quarter,MED,"Assist the Texas A&M System in pursuit of various projects, general government relations","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2013-04-18T12:37:11.363000-04:00
1377033,46ee8c93-1a34-4ada-9696-3059c06f0399,Q1,"W STRATEGIES, LLC",400605842,"23ANDME, INC.",2013,first_quarter,MED,Issues relating to regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-18T12:44:25.343000-04:00
1377050,281be5a1-9a4c-4d24-8486-3036f7888f43,Q1,"THE PETRIZZO GROUP, INC.",305932,OMEROS CORPORATION,2013,first_quarter,MED,"Advocate for federal funding for reaserch on traumatic brain injury, PTSD, and treatment of bleeding during surgery and trauma.","Defense, Dept of (DOD)",30000,,0,0,2013-04-18T12:49:36.277000-04:00
1377113,f36ca088-0226-48be-9ace-602a62444002,Q1,"THE PETRIZZO GROUP, INC.",305932,ALLEN INSTITUTE,2013,first_quarter,MED,Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative.,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",20000,,0,0,2013-04-18T13:08:57.730000-04:00
1377261,3fbfa146-348c-476d-8bc2-9fe5c608007a,Q1,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2013,first_quarter,MED,"Department of Veterans Affairs, Medical Research Issues
National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)",,62000,0,0,2013-04-18T13:39:45.847000-04:00
1377596,f887c09f-951f-40dd-bbcf-7b6a5cdc9a6a,Q1,"O'NEILL, ATHY & CASEY, P.C.",42752,COALITION OF BOSTON TEACHING HOSPITALS,2013,first_quarter,MED,"Funding for federally-sponsored medical research
H.R. 729, Medical Research Protection Act","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-18T14:28:51.777000-04:00
1377727,f6c74881-5b27-4a2c-ab72-71be2ef52144,Q1,AMERICAN ASSOCIATION OF COLLEGES OF NURSING,66911,AMERICAN ASSOCIATION OF COLLEGES OF NURSING,2013,first_quarter,MED,"Lobbied Members of Congress to protect funding for research in the FY 2013 and FY 2014 LHHS Appropriations through the National Institutes of Health, National Institute of Nursing Research, Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality.","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),President of the U.S.,SENATE",,40000,0,0,2013-04-18T14:43:45.623000-04:00
1377798,83df760e-2b11-43e6-98a4-4940ad97eaf3,Q1,COZEN O'CONNOR PUBLIC STRATEGIES,400459252,UNITED MITOCHONDRIAL DISEASE FOUNDATION,2013,first_quarter,MED,Federal funding for support and research on mitchondrial disease cures and prevention.,Executive Office of the President (EOP),,,0,0,2013-04-18T14:52:12.897000-04:00
1377824,8915cfa5-d4dc-4287-b839-081ad58864ff,Q1,"O'NEILL, ATHY & CASEY, P.C.",42752,MASS GENERAL BRIGHAM,2013,first_quarter,MED,"Funding for federally-sponsored medical research
H.R. 729, Medical Research Protection Act","HOUSE OF REPRESENTATIVES,SENATE",200000,,0,0,2013-04-18T14:53:22.053000-04:00
1378157,976a203a-ba4a-41e3-940c-611c0f221316,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION OF AMERICA'S BLOOD BANKS,2013,first_quarter,MED,"Blood safety and management issues.  HHS Advisory Committee on Blood Safety and Availability. 
Research related to Biovigilance.","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-18T15:24:41.277000-04:00
1378175,a89bad4b-3233-47a9-9adc-f398bd19b1e1,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2013,first_quarter,MED,Research in hematology.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2013-04-18T15:27:51.757000-04:00
1378200,844375e8-2c4d-4828-8ad9-fab052a17775,1A,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2013,first_quarter,MED,Research in hematology.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2013-04-18T15:31:00.130000-04:00
1378273,7487d89d-f349-45ea-84b6-37fa17cddca2,Q1,"WHITMER & WORRALL, LLC",292892,NEURO KINETICS,2013,first_quarter,MED,Issues related to Traumatic Brain Injury (TBI).,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",20000,,0,0,2013-04-18T15:37:23.283000-04:00
1378385,9ce3b964-3ef0-4152-892f-f2b9c186a93a,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2013,first_quarter,MED,Research and public health programs in epilepsy.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2013-04-18T15:53:17.193000-04:00
1378448,da12160a-3ea3-4c4b-9026-3fec48d51afd,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2013,first_quarter,MED,"Hemophilia research, prevention, surveillance and service programs and issues.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2013-04-18T15:58:41.140000-04:00
1378798,641978ab-54b6-4f7b-86fc-6d62628f4a8c,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,"SAGE PUBLICATIONS, INC.",2013,first_quarter,MED,"H933 Department of Defense, Military Construction and Veterans Affairs, and Full-Year Continuing Appropriations Act, 2013,
Coburn Amendment to shift funding from social sciences to cancer research.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",20000,,0,0,2013-04-18T16:29:00.990000-04:00
1378953,e3810691-c4d3-48e4-a663-21e9a4734a08,Q1,NORTHWESTERN UNIV,299992,NORTHWESTERN UNIV,2013,first_quarter,MED,"H.R. 1201, Training Tomorrow's Doctors Today, entire bill.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,138000,0,0,2013-04-18T16:43:09.620000-04:00
1379140,c2cd1e29-440b-432c-b9ad-3f074d320eef,Q1,IKARIA,400758262,IKARIA,2013,first_quarter,MED,Funding for rare disease research,"HOUSE OF REPRESENTATIVES,SENATE",,540000,0,0,2013-04-18T17:26:44.630000-04:00
1379163,809f10a6-8c26-4c44-bd11-9c206950ba6d,Q1,BRET HEALY D/B/A RIVERBLUFF STRATEGIES,400581777,"HEALTH EDUCATION RESOURCES AND OUTREACH, INC",2013,first_quarter,MED,Activities in support of a grant application to the Centers for Disease Control for a Type 2 diabetes education and outreach program.,SENATE,20000,,0,0,2013-04-18T17:31:56.097000-04:00
1379209,daf02162-a11a-4c3c-8dc8-741ceb1074ec,Q1,CHARLIE MCBRIDE ASSOCIATES,24214,BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA,2013,first_quarter,MED,To monitor legislation affecting medical energy research and technology-based economic development,"HOUSE OF REPRESENTATIVES,SENATE",7200,,0,0,2013-04-18T17:48:13.193000-04:00
1379544,26155390-d89f-4bf9-b903-6ca6fcb98d5e,Q1,"CROSSROADS STRATEGIES, LLC",400531586,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,2013,first_quarter,MED,"S.644, PACT Act; issues related to preventing abuse or diversion of over-the-counter drugs; Food and Drug Administration Safety and Innovation Act, Public Law No: 112-144; issues related to insuring access to over-the-counter drugs.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2013-04-18T21:46:33.430000-04:00
1379845,afde83f4-3b59-455f-8be4-b096a244bfaf,Q1,VENABLE LLP,39941,AMPHASTAR PHARMACEUTICALS INC.,2013,first_quarter,MED,Primatene Mist and Primatene HFA.,"Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-04-19T09:45:04.910000-04:00
1379984,900f388e-c825-48e6-a2ec-444ffd921db3,Q1,"OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC",30212,ASSOCIATION OF MEDICAL DEVICE REPROCESSORS,2013,first_quarter,MED,Monitor and advocate on legislation regarding third party medical device reprocessing.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-04-19T10:06:57.877000-04:00
1380118,40805b68-9947-4ec2-bf04-91f8580d99c6,Q1,UNIVERSITY OF KENTUCKY,400287372,UNIVERSITY OF KENTUCKY,2013,first_quarter,MED,FY14 funding for NIH and HRSA,"HOUSE OF REPRESENTATIVES,SENATE",,67000,0,0,2013-04-19T10:27:51.203000-04:00
1380321,278f9ec4-dc29-4415-9712-909f66d8502f,Q1,INFECTIOUS DISEASES SOCIETY OF AMERICA,54836,INFECTIOUS DISEASES SOCIETY OF AMERICA,2013,first_quarter,MED,Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policy to allow HIV+ to HIV+ organ transplants.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,120549,0,0,2013-04-19T10:48:10.530000-04:00
1380629,99f560d3-7493-42fa-8c5a-00f0bb82c5b5,Q1,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,3435,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,2013,first_quarter,MED,Appropriations for Federal Health Agencies; Stark Self Referral Reform; Workforce Investment Act -- Laboratory Workforce Shortages; Graduate Medical Education; Regualtion of Laboratory Developed Tests; Medicare: Clinical Laboratory Fee Schedule & Physician Fee Schedule,"Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE",,42000,0,0,2013-04-19T11:21:18.770000-04:00
1380917,7a14c24d-156c-467e-a313-759ace003269,Q1,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2013,first_quarter,MED,"Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2013 and FY 2014 Funding.  
Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-04-19T11:49:12.153000-04:00
1380936,624598e7-b1c6-44dc-aa1c-70be9adbdfb1,Q1,WILLIAMS MULLEN,47201,OWENS & MINOR,2013,first_quarter,MED,Issues related to medical supplies,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-04-19T11:52:20.587000-04:00
1381145,7ed0208c-b90c-4b2d-9519-1653d5144c73,Q1,GROUP HEALTH COOPERATIVE,17022,GROUP HEALTH COOPERATIVE,2013,first_quarter,MED,Health systems and medical research topics.,"Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Personnel Management (OPM),SENATE,White House Office",,130000,0,0,2013-04-19T12:23:36.110000-04:00